Thinking Beyond the Tumor: Integrating Germline Testing into Everyday Comprehensive Oncology Care

Discover how germline testing is reshaping comprehensive cancer care—from guiding treatment and surgical decisions to building risk assessment and survivorship into everyday workflows.

Jul 22, 2026
Providers
Webinar
Headshot of Thomas (T.J.) Slavin Jr.Thomas (T.J.) Slavin Jr., MD, MBA Chief Medical Officer, Tempus Diagnostics
Headshot of Alan TanAlan Tan, MDVice President, MRD Research & Clinical Strategy, Tempus Diagnostics
Headshot of Holly LaDucaHolly LaDuca, MS, CGC Clinical Strategy Manager, Tempus Diagnostics

Session highlights

  • Hear about current clinical guidelines on appropriate candidates for germline testing

  • See how germline results can directly influence personalized treatment selection, surgical decisions, and other aspects of care

  • Understand strategies for implementing comprehensive risk assessment and survivorship care into your workflows

Related content

Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Abstract gradient fading from white and gray to bright blue with soft, rounded edges.

ESMO Congress 2026

Providers
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Smooth vertical gradient transitioning from dark blue to light blue and white.

2026 ASCO® Annual Meeting

2026-04-13
Providers
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract background with a glowing blue-white curved line against a dark, textured surface.

From recurrence monitoring to treatment response: MRD data insights across the cancer care continuum

2026-05-11
Providers